Table 3.
Association between plasma microRNA levels and the endpoint in Phase II.
| miRNA | Univariable | Adjusted for matching variables (complete observations) |
Adjusted for matching variables (with imputation by the median) | Adjusted for matching variables (with MICE) | ||||
|---|---|---|---|---|---|---|---|---|
| HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | |
| miR-186-5p | ||||||||
| Continuous | 0.90 (0.71-1.14) | 0.39 | 0.95 (0.74-1.21) | 0.66 | 0.89 (0.70-1.13) | 0.33 | 0.89 (0.71-1.13) | 0.34 |
| > 1st tertile | 0.91 (0.68-1.22) | 0.52 | 0.96 (0.69-1.32) | 0.79 | 0.88 (0.65-1.19) | 0.41 | 0.88 (0.65-1.20) | 0.42 |
| > median | 0.84 (0.64-1.12) | 0.23 | 0.85 (0.63-1.15) | 0.29 | 0.81 (0.61-1.07) | 0.14 | 0.81 (0.61-1.07) | 0.14 |
| > 2nd tertile | 1.02 (0.76-1.37) | 0.91 | 1.02 (0.74-1.40) | 0.90 | 0.97 (0.72-1.32) | 0.86 | 0.98 (0.72-1.32) | 0.88 |
| miR-210-3p | ||||||||
| Continuous | 0.85 (0.65-1.10) | 0.22 | 1.06 (0.79-1.42) | 0.68 | 1.10 (0.83-1.45) | 0.49 | 1.11 (0.84-1.46) | 0.47 |
| > 1st tertile | 0.84 (0.63-1.12) | 0.24 | 1.06 (0.76-1.47) | 0.72 | 1.06 (0.78-1.45) | 0.70 | 1.07 (0.78-1.46) | 0.68 |
| > median | 0.74 (0.56-0.98) | 0.037 | 0.84 (0.62-1.15) | 0.27 | 0.87 (0.65-1.17) | 0.36 | 0.87 (0.65-1.17) | 0.36 |
| > 2nd tertile | 0.98 (0.73-1.32) | 0.92 | 1.06 (0.77-1.47) | 0.70 | 1.10 (0.81-1.49) | 0.56 | 1.09 (0.81-1.48) | 0.56 |
| miR-632 | ||||||||
| Continuous | 0.84 (0.67-1.06) | 0.14 | 0.93 (0.74-1.17) | 0.53 | 0.94 (0.75-1.18) | 0.58 | 0.94 (0.75-1.18) | 0.58 |
| > 1st tertile | 0.88 (0.66-1.17) | 0.38 | 1.02 (0.74-1.41) | 0.90 | 1.00 (0.74-1.36) | 1.00 | 1.00 (0.74-1.36) | 1.00 |
| > median | 0.88 (0.67-1.16) | 0.37 | 0.93 (0.68-1.26) | 0.62 | 0.96 (0.72-1.29) | 0.81 | 0.96 (0.72-1.29) | 0.80 |
| > 2nd tertile | 0.83 (0.61-1.12) | 0.22 | 0.88 (0.64-1.21) | 0.43 | 0.87 (0.64-1.19) | 0.39 | 0.87 (0.64-1.19) | 0.38 |
HR Hazard ratio; CI Confidence interval.